At the end of December, the FDA released its “Voice of the Patient Report: Lung Cancer”, the latest step inan Initiative focused on better incorporating patient voices in the review and approval process for lung cancer drugs and diagnostics. The American Lung Association is proud to have played a significant role in FDA taking this new, closer look at lung cancer treatment from the patient’s perspective.
↧